Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06686329Not ApplicableRecruiting

Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose

Role: collaborator

NCT01623934Active Not Recruiting

Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development

Role: collaborator

NCT03588234Completed

Food Literacy and Type 1 Diabetes

Role: collaborator

NCT01399645Phase 2Completed

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Role: collaborator

NCT01766557Not ApplicableCompleted

Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.

Role: collaborator

NCT01782105Not ApplicableCompleted

Intervention to Promote Changes of Healthy Lifestyle (Physical Activity and Nutrition) During Gestation

Role: collaborator

NCT01297946Phase 1Completed

Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 Diabetes

Role: collaborator

All 7 trials loaded